Vivos Therapeutics, Inc. VVOS 深 滬
已收盤 02-06 16:00:00 美东时间
1.55
+0.050
+3.33%
華盛通- 最 高1.5796
- 今 開1.50
- 成交量 8.76万股
- 最 低 1.47
- 昨 收 1.50
- 總市值 1770.12万
- 52周最高 7.95
- 市盈率 靜 --
- 換手率 0.77%
- 52周最低 1.4235
- 委 比 26.47%
- 總股本 1142.01万
- 歷史最高 360.25
- 量 比 0.63
- 振 幅 7.31%
- 歷史最低 1.4235
- 每 手 1
- 風險率 1.09%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Vivos Therapeutics Appoints Gregg Johnson to Board
An announcement from Vivos Therapeutics ( ($VVOS) ) is now available. Effective...
02-07 05:38
BUZZ-U.S. STOCKS ON THE MOVE-OneSpaWorld, IMUNON, Cigna
BUZZ-U.S. STOCKS ON THE MOVE-OneSpaWorld, IMUNON, Cigna Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 slid to near two-week lows and the Nasdaq sank to its lowest level
02-05 23:44
Vivos Therapeutics Partners with SoundHealth to Expand Access to Sleep and Allergy Technologies
Vivos Therapeutics Partners with SoundHealth to Expand Access to Sleep and Allergy Technologies Vivos Therapeutics Inc., a leader in medical devices and healthcare services for breathing-related sleep disorders, has announced a collaboration with SoundHealth, a Silicon Valley health technology compa
02-05 21:45
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter
The most oversold stocks in the health care sector presents an opportunity to b...
02-03 19:23
Vivos Therapeutics shares are trading lower after the company announced the exercise of warrants generating $4.64 million in gross proceeds.
Vivos Therapeutics shares are trading lower after the company announced the exe...
01-16 21:02
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds
Vivos Therapeutics, Inc. (VVOS) has entered into a definitive agreement to exercise outstanding warrants to purchase up to 1,982,356 shares at a reduced exercise price of $2.34 per share, generating approximately $4.64 million in gross proceeds. The company will issue new warrants for 3,964,712 shares at $2.09 per share, with varying expiration terms. The offering is expected to close on January 20, 2026, with proceeds used for working capital an...
01-16 13:00
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST
Vivos Therapeutics, Inc. (NASDAQ: VVOS) announced that CEO Kirk Huntsman and CFO Brad Amman will participate in a fireside chat on December 16, 2025, at 11:00 am ET with Robert Sassoon of Water Tower Research. The discussion will cover Vivos' strategic business model pivot, operational execution, market opportunity, competitive environment, growth, and financial strategies. The event is listen-only and available for registration at www.globenewsw...
2025-12-15 22:30
Vivos Therapeutics Secures $2M Note with Avondale
Vivos Therapeutics ( ($VVOS) ) has provided an announcement. On December 5, 202...
2025-12-06 06:28
美股大行评级 | 美鹰服饰、CrowdStrike、迈威尔科技获多家机构上调目标价；ACHC、GitLab、Okta遭多家机构下调目标价
今日重点评级关注：Guggenheim：维持Cybin Inc. Common Shares"买入"评级，目标价从39美元升至48美元；HC Wainwright & Co.：维持Capricor Therapeutics"买入"评级，目标价从24美元升至60美元
2025-12-04 09:38
Ascendiant Capital Maintains Buy on Vivos Therapeutics, Lowers Price Target to $5.5
Ascendiant Capital analyst Lucas Ward maintains Vivos Therapeutics (NASDAQ:VVOS) with a Buy and lowers the price target from $6.5 to $5.5.
2025-12-03 19:47
